Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1994Clinical Infectious Diseases

Phase 2 Efficacy Trial of an Oral 8-Aminoquinoline (WR6026) for Treatment of Visceral Leishmaniasis

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJames A. SherwoodUniversity of Massachusetts LowellGGG. GachihiUnited States Food and Drug AdministrationRMR. MuigaiUniversity of Nairobi

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sherwood et al. (1994) studied this question.

synapsesocial.com/papers/6a9136512d14ef2b6ea15496https://doi.org/10.1093/clinids/19.6.1034
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1THE CLINICAL TRIAL OF EIGHTEEN ANALOGUES OF PAMAQUIN (PLASMOCHIN) IN VIV AX MALARIA (CHESSON STRAIN) 11948 · 34 citations
  2. 2Experimental Therapy of Mice Infected with Leishmania Tropica1979 · 10 citations
  3. 3The culture of Leishmania donovani in Schneider's insect medium: its value in the diagnosis and management of patients with visceral leishmaniasis1981 · 31 citations
  4. 4The Antileishmanial Activity of Lepidines1978 · 57 citations